Alacris is proud to be one of the four finalists in the category „Start-Up-Companies“. A committee of representatives from industry and science considered the 200 applications. Criteria for the award alongside the level of innovation are marketability, innovation management and sustainability of the business concept. The oldest innovation award in the world is awarded in […]
The STEP Award is a competition to reward innovative and high-growth companies in Germany, Austria and Switzerland and to give companies in the growth phase impetus for their successful development. Accordingly growth industries like pharma and life science are in the focus of the competition. We are delighted to have convinced the jury with our […]
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments Berlin, 29th July 2015 – Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children. It can occur in various forms, differing not only by specific changes in the genetic material of the leukemia cells […]
The Deutsche Innovationspreis 2015 was awarded in Munich on Friday, April 24th. Alacris is the proud winner in the category Small and Medium Sized Enterprises.Our innovation ModCellTM convinced the jury. They agree with us that our systems biology approach not only helps physicians and clinics to find the right drug for the right patient. It […]
Alacris Theranostics is very pleased to be one of 14 finalists of the Deutssche Innovationpreises 2015. With ModCellTM Alacris is among the “best inventions” in Germany in 2015. The award ceremony will take place in Munich on April, 24th.
Alacris is one of the partners of CANCER-ID, a newly formed European consortium funded by the Innovative Medicines Initiative (IMI). CANCER-ID consists of currently 33 partners from 13 countries aiming at the establishment of standard protocols for and clinical validation of blood-based biomarkers. The consortium brings together experts from academic and clinical research, innovative Small-to-Medium […]
Berlin, 27th February 2015 – The teams led by Marie-Laure Yaspo at the Max Planck Institute for Molecular Genetics and by Hans Lehrach at Alacris Theranostics GmbH in Berlin are partners in a European consortium that recently obtained funding from the European Commission under the Horizon 2020 program to participate in a clinical research project […]
Alacris is proud to be one of the four finalists in the category „Start-Up-Companies“. A committee of representatives from industry and science considered the 200 applications. Criteria for the award alongside the level of innovation are marketability, innovation management and sustainability of the business concept. The oldest innovation award in the world is awarded in […]